Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Aspirin, Heparin, or Both to Treat Acute Unstable Angina

Pierre Théroux, Hélène Ouimet, John McCans et al. · New England Journal of Medicine · 1988 · 1.3K citations

Medicine, Cardiology, Pharmacotherapy +13

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

J. H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · 1987 · 735 citations

Medicine, Cardiology, Internal Medicine +11

The Bleeding Time as a Screening Test for Evaluation of Platelet Function

Laurence A. Harker, Sherrill J. Slichter · New England Journal of Medicine · 1972 · 570 citations

Medicine, Hematology, Chemotherapy +16

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.

Herman K. Gold, Barry S. Coller, Tsunehiro Yasuda et al. · Circulation · 1988 · 393 citations

Medicine, Cardiology, Pharmacotherapy +15